CASI Pharmaceuticals
CASI
#10982
Rank
NZ$7.23 M
Marketcap
NZ$0.35
Share price
0.00%
Change (1 day)
-87.89%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): NZ-$4.65

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.70. In 2024 the company made an earnings per share (EPS) of NZ-$4.35 a decrease over its 2023 EPS that were of NZ-$3.43.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.657.03%
2024NZ-$4.3526.73%
2023NZ-$3.43-32.89%
2022NZ-$5.1111.9%
2021NZ-$4.57-38.44%
2020NZ-$7.42-8.96%
2019NZ-$8.1550%
2018NZ-$5.4377.78%
2017NZ-$3.065.88%
2016NZ-$2.89-22.73%
2015NZ-$3.73-76.09%
2014NZ-$15.62318.18%
2013NZ-$3.73-71.79%
2012NZ-$13.2465.96%
2011NZ-$7.98-50%
2010NZ-$15.96-18.97%
2009NZ-$19.69-63.64%
2008NZ-$54.153.57%
2007NZ-$52.29-60.56%
2006NZ-$132.5897.22%
2005NZ-$67.23-2.7%
2004NZ-$69.09-45.59%
2003NZ-$126.98-61.8%
2002NZ-$332.39-25.52%
2001NZ-$446.30-21.38%
2000NZ-$567.6813.86%
1999NZ-$498.59149.53%
1998NZ-$199.8198.15%
1997NZ-$100.8410.2%
1996NZ-$91.50